IP Library › Granted Patent US 11,352,629
Granted Patent B2
US 11,352,629 · App. 15/735,707 · Granted Jun 7, 2022

Defined multi-conjugate oligonucleotides

Inventors: Philipp Hadwiger (Kulmbach, DE); Hans-Peter Vornlocher (Kulmbach, DE); Jonathan Miles Brown (Chevy Chase, MD); James Everett Dahlman (Atlanta, GA); Kristin K. H. Neuman (Larchmont, NY)
Assignee: MPEG LA, L.L.C.
C12N15/115A61K9/127A61K47/549A61K47/6911C12N15/111C12N15/113C12N2310/14C12N2310/315C12N2310/317C12N2310/321C12N2310/322C12N2310/346C12N2310/351C12N2310/3521C12N2310/3533C12N2310/51
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,352,629
App. No.
15/735,707
Granted
Jun 7, 2022
Kind
B2
Abstract

Defined multi-conjugate oligonucleotides can have predetermined sizes and compositions. For example, in various embodiment, defined multi-conjugate oligonucleotides can have advantageous properties, for example in the form of defined multi-conjugate siRNA (i.e., including two, three or more siRNA) having enhanced intracellular delivery and/or multi-gene silencing effects. In various embodiment, the defined multi-conjugate oligonucleotides can be synthesized via new synthetic intermediates and methods. The defined multi-conjugate oligonucleotides can be used, for example, in reducing gene expression, biological research, treating or preventing medical conditions, or to produce new or altered phenotypes in cells or organisms.

Claims (25)

1. An isolated compound according to Structure 1:

X—R1-R2-A-R3-B  (Structure 1)

wherein:

X is a nucleic acid bonded to R1 through its 3′ or 5′ terminus;

R1 is a phosphodiester, thiophosphodiester, sulfate, amide, glycol, or is absent;

R2 is a C2-C10 alkyl, alkoxy, or aryl group, or is absent;

A comprises a reaction product of a first nucleophile and a first electrophile;

R3 comprises C2-C10 alkyl, alkoxy, aryl, alkyldithio, ether, thioether, ester, thiopropionate, or disulfide; and

B is a group that comprises a second nucleophile or a second electrophile, wherein the second nucleophile is the same as the first nucleophile, and the second electrophile is the same as the first electrophile.

2. The isolated compound of claim 1 , wherein the first nucleophile and the first electrophile of A comprise (i) a thiol and a maleimide, (ii) a thiol and a vinylsulfone, (iii) a thiol and a pyridyldisulfide, (iv) a thiol and an iodoacetamide, (v) a thiol and an acrylate, (vi) an azide and an alkyne, or (vii) an amine and a carboxyl group.

3. The isolated compound of claim 1 , wherein:

R1 is a phosphodiester or thiophosphodiester;

R2 is a C2-C10 alkyl or alkoxy:

R3 is cleavable intracellularly; and

the first nucleophile and the second nucleophile are both thiol, and the first electrophile and the second electrophile are both maleimide.

4. The isolated compound of claim 3 , wherein:

R1 is a phosphodiester;

R2 is a C2-C10 alkyl; and

R3 comprises an alkyldithio.

5. The isolated compound of claim 1 , wherein the compound further comprises a targeting ligand.

6. The isolated compound of claim 2 , wherein the reaction product of a thiol and a maleimide is a derivative of succinamic acid.

7. The isolated compound of claim 3 , wherein the reaction product of a thiol and a maleimide is a derivative of succinamic acid.

8. The isolated compound of claim 1 , wherein the compound is greater than or equal to 75% pure.

9. The isolated compound of claim 1 , wherein the compound is greater than or equal to 85% pure.

10. The isolated compound of claim 1 , wherein the compound is greater than or equal to 95% pure.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2019
From: BROWN, JONATHAN MILES; DAHLMAN, JAMES EVERETT; NEUMAN, KRISTIN K. H.
To: MPEG LA, LLC
Reel/Frame 051222/0348 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2019
From: VORNLOCHER, HANS-PETER; HADWIGER, PHILIPP
To: AXOLABS GMBH
Reel/Frame 051222/0353 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2019
From: AXOLABS GMBH
To: MPEG LA, LLC
Reel/Frame 051222/0364 →
Continuity (8)
Provisional Application 62175709 · Jun 15, 2015
Provisional Application 62175714 · Jun 15, 2015
Provisional Application 62175718 · Jun 15, 2015
Provisional Application 62203243 · Aug 10, 2015
Provisional Application 62216317 · Sep 9, 2015
Provisional Application 62216314 · Sep 9, 2015
Provisional Application 62216318 · Sep 9, 2015
Related Publication 20190085331A1 · Mar 21, 2019
Cited By (2)
US 12,378,551 US 12,618,071